Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Hepatitis A and B vaccine added to export ban list

The hepatitis A and B vaccine has been added to the list of medicines that cannot be parallel exported from the UK.

There are now 32 medicines on the list, issued by the Department of Health and Social Care, including alogliptin/metformin, the measles, mumps and rubella vaccine, the pneumococcal polysaccharide vaccine and misoprostol, which were all added in November 2019.

The restrictions prevent medicine wholesalers from parallel exporting — where companies buy medicines meant for UK patients and sell them on at a higher price in another country.

Manufacturers and wholesalers who are found guilty of parallel exporting one or more of the listed medicines could face regulatory action by the Medicines and Healthcare products Regulatory Agency, including the immediate suspension of their wholesale dealer licence.

In October 2019, the government announced restrictions on the parallel exporting of 19 hormone replacement therapy (HRT) products to tackle shortages in the UK.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207329

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.